Efficacy of the Targeted Triple Therapy With Giltertinib, Venetoclax, and Azacitidine as a Bridge to Allogenic Hematopoietic Stem Cell Transplant in Relapsed Refractory FLT3-Positive Acute Myeloid Leukemia in Children.

Authors

Yamini Krishnan, Smitha Bhaskaran, Gazel Sainulabdin, Krishnan Vettakorumakankavu Parameswaran

Published in

Pediatric blood & cancer. Pages e70427. Jul 21, 2026. Epub Jul 21, 2026.

PMID:
42479953
Bibliographic data and abstract were imported from PubMed on 22 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.